Pancreatic Cancer Research

RetractionPLoS One2018

Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer.

Journal
PLoS One
Published
2 October 2018
Citations
0
Type
Retraction
License
cc by
Full text
Open access, reuse-licensed (cc by)
Retracted
Yes

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try